A virtual workshop in November 2022 highlighted the importance of developing mucosal vaccines for SARS-CoV-2 that could reduce transmission and infection. Participants discussed challenges and…
A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found that it was safe and stimulated both antibodies and responses…
NIH scientists find that IV administration improves tumor-fighting action. An experimental therapeutic cancer vaccine induced two distinct and desirable immune system responses that led to…
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has launched an early-stage clinical trial to evaluate…
Study Includes Multiple Variant Vaccines Adults interested in joining this study should visit ClinicalTrials.gov and search identifier NCT05289037 for a list of sites and contacts….
Phase 1 Study Is Among First to Examine mRNA Technology for HIV. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National…
Achieving classical herd immunity against SARS-CoV-2, the virus that causes COVID-19, may not be attainable, according to a new perspective published in The Journal of…
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) are conducting a clinical trial designed to help understand rare but potentially serious systemic…
NIAID-sponsored study assessed dose in adults fully vaccinated with any EUA or approved COVID-19 vaccine. In adults who had previously received a full regimen of…
A clinical trial funded by the National Institutes of Health has found that giving peanut oral immunotherapy to highly peanut-allergic children ages 1 to 3…
On December 20, 2021, the U.S. Food and Drug Administration announced its first approval of a long-acting HIV prevention medication. Developed by ViiV Healthcare, the…
A growing body of scientific evidence, considered together with ecological reality, strongly suggest that novel coronaviruses will continue to infect bats and other animal reservoirs…
NIH scientists developed vaccine platform. An experimental HIV vaccine based on mRNA—the same platform technology used in two highly effective COVID-19 vaccines—shows promise in mice…
SARS-CoV-2 prevents lung tissue repair, regeneration. Lung autopsy and plasma samples from people who died of COVID-19 have provided a clearer picture of how the…
Different mechanisms suppressed the virus in each person. Research led by scientists at the National Institutes of Health has identified two distinct ways that people…
A clinical trial has found that treatment with the immunomodulator interferon beta-1a plus the antiviral remdesivir was not superior to treatment with remdesivir alone in…
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded approximately $36.3 million to three academic institutions…
Trial also will test pausing immunosuppressive medication to improve antibody response. The National Institutes of Health has begun a clinical trial to assess the antibody…
